The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer

Authors

Andrew Wardley, University of Manchester
Ron Bose, Washington University School of Medicine in St. Louis
et al

Journal

Breast cancer research and treatment

Publication Date

5-1-2021

Volume

187

Issue

1

First Page

155

Last Page

165

Document Type

Open Access Publication

DOI

10.1007/s10549-021-06109-7

Rights and Permissions

Wardley, A., Cortes, J., Provencher, L. et al. The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer. Breast Cancer Res Treat 187, 155–165 (2021). https://doi.org/10.1007/s10549-021-06109-7 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Wardley, Andrew; Bose, Ron; and al, et, "The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer." Breast cancer research and treatment. 187, 1. 155 - 165. (2021).
https://digitalcommons.wustl.edu/oa_4/442